Skip to main content

Advertisement

Open Peer Review Reports for: Prognostic role of CD4 T-cell depletion after frontline fludarabine, cyclophosphamide and rituximab in chronic lymphocytic leukaemia

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
3 Oct 2018 Submitted Original manuscript
20 Nov 2018 Reviewed Reviewer Report - Kallesh Danappa Jayappa
18 Jan 2019 Author responded Author comments - Martin Gauthier
Resubmission - Version 2
18 Jan 2019 Submitted Manuscript version 2
16 Feb 2019 Reviewed Reviewer Report - Kallesh Danappa Jayappa
18 Feb 2019 Author responded Author comments - Martin Gauthier
Resubmission - Version 3
18 Feb 2019 Submitted Manuscript version 3
24 Feb 2019 Reviewed Reviewer Report - Kallesh Danappa Jayappa
14 May 2019 Reviewed Reviewer Report - Yair Herishanu
29 May 2019 Reviewed Reviewer Report - Reviewer 2
6 Jun 2019 Author responded Author comments - Martin Gauthier
Resubmission - Version 4
6 Jun 2019 Submitted Manuscript version 4
18 Jul 2019 Author responded Author comments - Martin Gauthier
Resubmission - Version 5
18 Jul 2019 Submitted Manuscript version 5
21 Jul 2019 Author responded Author comments - Martin Gauthier
Resubmission - Version 6
21 Jul 2019 Submitted Manuscript version 6
Publishing
23 Jul 2019 Editorially accepted
14 Aug 2019 Article published 10.1186/s12885-019-5971-z

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement